Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy
Abstract Objectives Our study aimed to determine the prevalence and prognosis of acute coronary syndrome with non-obstructive coronary artery (ACS-NOCA) in patients with hypertrophic cardiomyopathy (HCM). Methods and results We enrolled a total of 200 consecutive patients with HCM over a 139-month p...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbe4d21018f8493d82ee62ade22df081 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:dbe4d21018f8493d82ee62ade22df081 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:dbe4d21018f8493d82ee62ade22df0812021-11-21T12:04:09ZAcute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy10.1186/s12872-021-02373-z1471-2261https://doaj.org/article/dbe4d21018f8493d82ee62ade22df0812021-11-01T00:00:00Zhttps://doi.org/10.1186/s12872-021-02373-zhttps://doaj.org/toc/1471-2261Abstract Objectives Our study aimed to determine the prevalence and prognosis of acute coronary syndrome with non-obstructive coronary artery (ACS-NOCA) in patients with hypertrophic cardiomyopathy (HCM). Methods and results We enrolled a total of 200 consecutive patients with HCM over a 139-month period from 2002 to 2013. The study found that 28 patients (14% of overall patients, 51% of patients with ACS) had ACS-NOCA, and 18 patients (9% of overall patients, 86% of patients with acute MI) had MINOCA as initial clinical presentations. The highest prevalence of non-obstructive coronary artery disease (NOCA) in patients with HCM was found in acute ST-elevation myocardial infarction (STEMI) (100%), followed by non-STEMI (82%), and unstable angina (29%). Patients with ACS-NOCA had more frequent ventricular tachycardia and lower resting left ventricular (LV) outflow tract gradients than those with no ACS-NOCA (p < 0.05 for all). The ACS-NOCA group had a lower probability of HCM-related death compared with the no ACS-NOCA group and the significant coronary artery disease (CAD) group (p-log-rank = 0.0018). Conclusions MINOCA or ACS-NOCA is not an uncommon initial presentation (prevalence rate 9–14%) in patients with HCM. NOCA was highly prevalent (51–86%) in patients with HCM presenting with ACS and had a favorable prognosis. Our findings highlight as a reminder that in an era of rapid reperfusion therapy, ACS in patients with HCM is not only a result of obstructive epicardial CAD, but also stems from the complex cellular mechanisms of myocardial necrosis.Sarinya PuwanantAngkawipa TrongtorsakChaisiri WanlapakornNattakorn SongsirisukAekarach AriyachaipanichSmonporn BoonyaratavejBMCarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENBMC Cardiovascular Disorders, Vol 21, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Sarinya Puwanant Angkawipa Trongtorsak Chaisiri Wanlapakorn Nattakorn Songsirisuk Aekarach Ariyachaipanich Smonporn Boonyaratavej Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy |
description |
Abstract Objectives Our study aimed to determine the prevalence and prognosis of acute coronary syndrome with non-obstructive coronary artery (ACS-NOCA) in patients with hypertrophic cardiomyopathy (HCM). Methods and results We enrolled a total of 200 consecutive patients with HCM over a 139-month period from 2002 to 2013. The study found that 28 patients (14% of overall patients, 51% of patients with ACS) had ACS-NOCA, and 18 patients (9% of overall patients, 86% of patients with acute MI) had MINOCA as initial clinical presentations. The highest prevalence of non-obstructive coronary artery disease (NOCA) in patients with HCM was found in acute ST-elevation myocardial infarction (STEMI) (100%), followed by non-STEMI (82%), and unstable angina (29%). Patients with ACS-NOCA had more frequent ventricular tachycardia and lower resting left ventricular (LV) outflow tract gradients than those with no ACS-NOCA (p < 0.05 for all). The ACS-NOCA group had a lower probability of HCM-related death compared with the no ACS-NOCA group and the significant coronary artery disease (CAD) group (p-log-rank = 0.0018). Conclusions MINOCA or ACS-NOCA is not an uncommon initial presentation (prevalence rate 9–14%) in patients with HCM. NOCA was highly prevalent (51–86%) in patients with HCM presenting with ACS and had a favorable prognosis. Our findings highlight as a reminder that in an era of rapid reperfusion therapy, ACS in patients with HCM is not only a result of obstructive epicardial CAD, but also stems from the complex cellular mechanisms of myocardial necrosis. |
format |
article |
author |
Sarinya Puwanant Angkawipa Trongtorsak Chaisiri Wanlapakorn Nattakorn Songsirisuk Aekarach Ariyachaipanich Smonporn Boonyaratavej |
author_facet |
Sarinya Puwanant Angkawipa Trongtorsak Chaisiri Wanlapakorn Nattakorn Songsirisuk Aekarach Ariyachaipanich Smonporn Boonyaratavej |
author_sort |
Sarinya Puwanant |
title |
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy |
title_short |
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy |
title_full |
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy |
title_fullStr |
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy |
title_full_unstemmed |
Acute coronary syndrome with non-obstructive coronary arteries (ACS-NOCA) in patients with hypertrophic cardiomyopathy |
title_sort |
acute coronary syndrome with non-obstructive coronary arteries (acs-noca) in patients with hypertrophic cardiomyopathy |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/dbe4d21018f8493d82ee62ade22df081 |
work_keys_str_mv |
AT sarinyapuwanant acutecoronarysyndromewithnonobstructivecoronaryarteriesacsnocainpatientswithhypertrophiccardiomyopathy AT angkawipatrongtorsak acutecoronarysyndromewithnonobstructivecoronaryarteriesacsnocainpatientswithhypertrophiccardiomyopathy AT chaisiriwanlapakorn acutecoronarysyndromewithnonobstructivecoronaryarteriesacsnocainpatientswithhypertrophiccardiomyopathy AT nattakornsongsirisuk acutecoronarysyndromewithnonobstructivecoronaryarteriesacsnocainpatientswithhypertrophiccardiomyopathy AT aekarachariyachaipanich acutecoronarysyndromewithnonobstructivecoronaryarteriesacsnocainpatientswithhypertrophiccardiomyopathy AT smonpornboonyaratavej acutecoronarysyndromewithnonobstructivecoronaryarteriesacsnocainpatientswithhypertrophiccardiomyopathy |
_version_ |
1718419275960549376 |